Different States Of Cancer Stem Cells


Ontology type: sgo:Patent     


Patent Info

DATE

N/A

AUTHORS

Suling Liu , Max S. Wicha

ABSTRACT

Compositions, kits, and methods for therapeutic screening, diagnostics, and cancer treatment based on the identification or use of the different states of cancer stem cells, including cancer stem cells in the EMT (epithelial to mesenchymal transition) MET (mesenchymal to epithelial transition), and EMT-MET states are disclosed. In some methods, a subject is treated with one therapeutic that targets EMT cancer stem cells and a second therapeutic that targets MET cancers stem cells. In certain methods, the different states of cancer stem cells are distinguished based on markers CD44+CD24−, EpCam−CD49P+(for EMT cancers stem cells), ALDH+ and EPCam+CD49r− (for MET cancers stem cells), and CD44+CD24−ALDH+ (for EMT-MET cancer stem cells). In particular methods, micro RNAs are used to transition to one particular cancer stem cell type (e.g., mir-100 for EMT and mir-93 for MET). More... »

Related SciGraph Publications

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/3142", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "name": "Suling Liu", 
        "type": "Person"
      }, 
      {
        "name": "Max S. Wicha", 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1093/carcin/bgr110", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008823630"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s10555-008-9179-y", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011194150", 
          "https://doi.org/10.1007/s10555-008-9179-y"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.18632/aging.100285", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1068670611"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "description": "

Compositions, kits, and methods for therapeutic screening, diagnostics, and cancer treatment based on the identification or use of the different states of cancer stem cells, including cancer stem cells in the EMT (epithelial to mesenchymal transition) MET (mesenchymal to epithelial transition), and EMT-MET states are disclosed. In some methods, a subject is treated with one therapeutic that targets EMT cancer stem cells and a second therapeutic that targets MET cancers stem cells. In certain methods, the different states of cancer stem cells are distinguished based on markers CD44+CD24−, EpCam−CD49P+(for EMT cancers stem cells), ALDH+ and EPCam+CD49r− (for MET cancers stem cells), and CD44+CD24−ALDH+ (for EMT-MET cancer stem cells). In particular methods, micro RNAs are used to transition to one particular cancer stem cell type (e.g., mir-100 for EMT and mir-93 for MET).

", "id": "sg:patent.US-20150125469-A1", "keywords": [ "different state", "composition", "kit", "method", "therapeutic", "diagnostics", "cancer treatment", "Neoplastic Stem Cell", "EMT", "mesenchymal transition", "MetS", "transition", "state", "stem cell", "marker", "particular method", "micro RNAs", "stem cell type" ], "name": "DIFFERENT STATES OF CANCER STEM CELLS", "recipient": [ { "id": "https://www.grid.ac/institutes/grid.214458.e", "type": "Organization" } ], "sameAs": [ "https://app.dimensions.ai/details/patent/US-20150125469-A1" ], "sdDataset": "patents", "sdDatePublished": "2019-03-07T15:33", "sdLicense": "https://scigraph.springernature.com/explorer/license/", "sdPublisher": { "name": "Springer Nature - SN SciGraph project", "type": "Organization" }, "sdSource": "s3://com.uberresearch.data.dev.patents-pipeline/full_run_10/sn-export/5eb3e5a348d7f117b22cc85fb0b02730/0000100128-0000348334/json_export_820f844a.jsonl", "type": "Patent" } ]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/patent.US-20150125469-A1'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/patent.US-20150125469-A1'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/patent.US-20150125469-A1'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/patent.US-20150125469-A1'


 

This table displays all metadata directly associated to this object as RDF triples.

53 TRIPLES      14 PREDICATES      34 URIs      25 LITERALS      2 BLANK NODES

Subject Predicate Object
1 sg:patent.US-20150125469-A1 schema:about anzsrc-for:3142
2 schema:author N226a88aa4dec49fa87906b6428ffc886
3 schema:citation sg:pub.10.1007/s10555-008-9179-y
4 https://doi.org/10.1093/carcin/bgr110
5 https://doi.org/10.18632/aging.100285
6 schema:description <p id="p-0001" num="0000">Compositions, kits, and methods for therapeutic screening, diagnostics, and cancer treatment based on the identification or use of the different states of cancer stem cells, including cancer stem cells in the EMT (epithelial to mesenchymal transition) MET (mesenchymal to epithelial transition), and EMT-MET states are disclosed. In some methods, a subject is treated with one therapeutic that targets EMT cancer stem cells and a second therapeutic that targets MET cancers stem cells. In certain methods, the different states of cancer stem cells are distinguished based on markers CD44+CD24&#8722;, EpCam&#8722;CD49P+(for EMT cancers stem cells), ALDH+ and EPCam+CD49r&#8722; (for MET cancers stem cells), and CD44+CD24&#8722;ALDH+ (for EMT-MET cancer stem cells). In particular methods, micro RNAs are used to transition to one particular cancer stem cell type (e.g., mir-100 for EMT and mir-93 for MET).</p>
7 schema:keywords EMT
8 MetS
9 Neoplastic Stem Cell
10 cancer treatment
11 composition
12 diagnostics
13 different state
14 kit
15 marker
16 mesenchymal transition
17 method
18 micro RNAs
19 particular method
20 state
21 stem cell
22 stem cell type
23 therapeutic
24 transition
25 schema:name DIFFERENT STATES OF CANCER STEM CELLS
26 schema:recipient https://www.grid.ac/institutes/grid.214458.e
27 schema:sameAs https://app.dimensions.ai/details/patent/US-20150125469-A1
28 schema:sdDatePublished 2019-03-07T15:33
29 schema:sdLicense https://scigraph.springernature.com/explorer/license/
30 schema:sdPublisher N578db782dd0845b7b59e0d89d20e237e
31 sgo:license sg:explorer/license/
32 sgo:sdDataset patents
33 rdf:type sgo:Patent
34 N226a88aa4dec49fa87906b6428ffc886 rdf:first N92663b4ae1cb44dcac0f78838f36def3
35 rdf:rest Neb0017f916a5430baed40697c6912bd9
36 N578db782dd0845b7b59e0d89d20e237e schema:name Springer Nature - SN SciGraph project
37 rdf:type schema:Organization
38 N6897eea069e745f49d6c28075c9bc0e8 schema:name Max S. Wicha
39 rdf:type schema:Person
40 N92663b4ae1cb44dcac0f78838f36def3 schema:name Suling Liu
41 rdf:type schema:Person
42 Neb0017f916a5430baed40697c6912bd9 rdf:first N6897eea069e745f49d6c28075c9bc0e8
43 rdf:rest rdf:nil
44 anzsrc-for:3142 schema:inDefinedTermSet anzsrc-for:
45 rdf:type schema:DefinedTerm
46 sg:pub.10.1007/s10555-008-9179-y schema:sameAs https://app.dimensions.ai/details/publication/pub.1011194150
47 https://doi.org/10.1007/s10555-008-9179-y
48 rdf:type schema:CreativeWork
49 https://doi.org/10.1093/carcin/bgr110 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008823630
50 rdf:type schema:CreativeWork
51 https://doi.org/10.18632/aging.100285 schema:sameAs https://app.dimensions.ai/details/publication/pub.1068670611
52 rdf:type schema:CreativeWork
53 https://www.grid.ac/institutes/grid.214458.e schema:Organization
 




Preview window. Press ESC to close (or click here)


...